Shopping Cart
- Remove All
Your shopping cart is currently empty
PW507
PW507 is a potent, blood-brain barrier penetrable, and selective sigma 1 receptor (S1R) antagonist with a Ki value of 7.5 nM against human S1R. It exhibits lower binding affinity for S2R and hERG. This compound is utilized in the study of painful diabetic neuropathy (PDN).
Catalog No. T89328Cas No. 2573850-59-4
Resource Download
PW507
Catalog No. T89328Cas No. 2573850-59-4
PW507 is a potent, blood-brain barrier penetrable, and selective sigma 1 receptor (S1R) antagonist with a Ki value of 7.5 nM against human S1R. It exhibits lower binding affinity for S2R and hERG. This compound is utilized in the study of painful diabetic neuropathy (PDN).
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose. | Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks |
Bulk & Custom
Add to Cart
Questions
View MoreProduct Introduction
Bioactivity
Chemical Properties
| Description | PW507 is a potent, blood-brain barrier penetrable, and selective sigma 1 receptor (S1R) antagonist with a Ki value of 7.5 nM against human S1R. It exhibits lower binding affinity for S2R and hERG. This compound is utilized in the study of painful diabetic neuropathy (PDN). |
| In vitro | PW507 binds to the orthosteric site of the human S1R crystal structure and engages in strong interactions with the receptor. |
| In vivo | PW507 (20 mg/kg; intraperitoneal injection; twice daily; for 14 days) demonstrated significant therapeutic efficacy in alleviating mechanical allodynia. |
| Molecular Weight | 334.89 |
| Formula | C18H27ClN4 |
| Cas No. | 2573850-59-4 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy PW507 | purchase PW507 | PW507 cost | order PW507 | PW507 chemical structure | PW507 in vivo | PW507 in vitro | PW507 formula | PW507 molecular weight
- TOP
Feedback
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.